Copyright Reports & Markets. All rights reserved.

Global Infant and Child Multiple Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Infant and Child Multiple Vaccine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Infant and Child Multiple Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Pentavalent Vaccine
    • 1.3.3 Quadruple Vaccine
    • 1.3.4 Triple Vaccine
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Infant and Child Multiple Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 12 Months Below
    • 1.4.3 12 Months Above
  • 1.5 Global Infant and Child Multiple Vaccine Market Size & Forecast
    • 1.5.1 Global Infant and Child Multiple Vaccine Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Infant and Child Multiple Vaccine Sales Quantity (2018-2029)
    • 1.5.3 Global Infant and Child Multiple Vaccine Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Infant and Child Multiple Vaccine Product and Services
    • 2.1.4 Sanofi Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK Infant and Child Multiple Vaccine Product and Services
    • 2.2.4 GSK Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Mitsubishi Tanabe Pharma
    • 2.3.1 Mitsubishi Tanabe Pharma Details
    • 2.3.2 Mitsubishi Tanabe Pharma Major Business
    • 2.3.3 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product and Services
    • 2.3.4 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
  • 2.4 KM Biologics
    • 2.4.1 KM Biologics Details
    • 2.4.2 KM Biologics Major Business
    • 2.4.3 KM Biologics Infant and Child Multiple Vaccine Product and Services
    • 2.4.4 KM Biologics Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 KM Biologics Recent Developments/Updates
  • 2.5 Wuhan Institute of Biological Products
    • 2.5.1 Wuhan Institute of Biological Products Details
    • 2.5.2 Wuhan Institute of Biological Products Major Business
    • 2.5.3 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
    • 2.5.4 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
  • 2.6 Walvax Biotechnology
    • 2.6.1 Walvax Biotechnology Details
    • 2.6.2 Walvax Biotechnology Major Business
    • 2.6.3 Walvax Biotechnology Infant and Child Multiple Vaccine Product and Services
    • 2.6.4 Walvax Biotechnology Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Walvax Biotechnology Recent Developments/Updates
  • 2.7 Chengdu Institute of Biological Products
    • 2.7.1 Chengdu Institute of Biological Products Details
    • 2.7.2 Chengdu Institute of Biological Products Major Business
    • 2.7.3 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
    • 2.7.4 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
  • 2.8 Minhai Biotechnology
    • 2.8.1 Minhai Biotechnology Details
    • 2.8.2 Minhai Biotechnology Major Business
    • 2.8.3 Minhai Biotechnology Infant and Child Multiple Vaccine Product and Services
    • 2.8.4 Minhai Biotechnology Infant and Child Multiple Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Minhai Biotechnology Recent Developments/Updates

3 Competitive Environment: Infant and Child Multiple Vaccine by Manufacturer

  • 3.1 Global Infant and Child Multiple Vaccine Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Infant and Child Multiple Vaccine Revenue by Manufacturer (2018-2023)
  • 3.3 Global Infant and Child Multiple Vaccine Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Infant and Child Multiple Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Infant and Child Multiple Vaccine Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Infant and Child Multiple Vaccine Manufacturer Market Share in 2022
  • 3.5 Infant and Child Multiple Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Infant and Child Multiple Vaccine Market: Region Footprint
    • 3.5.2 Infant and Child Multiple Vaccine Market: Company Product Type Footprint
    • 3.5.3 Infant and Child Multiple Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Infant and Child Multiple Vaccine Market Size by Region
    • 4.1.1 Global Infant and Child Multiple Vaccine Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Infant and Child Multiple Vaccine Consumption Value by Region (2018-2029)
    • 4.1.3 Global Infant and Child Multiple Vaccine Average Price by Region (2018-2029)
  • 4.2 North America Infant and Child Multiple Vaccine Consumption Value (2018-2029)
  • 4.3 Europe Infant and Child Multiple Vaccine Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Infant and Child Multiple Vaccine Consumption Value (2018-2029)
  • 4.5 South America Infant and Child Multiple Vaccine Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Infant and Child Multiple Vaccine Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Infant and Child Multiple Vaccine Sales Quantity by Type (2018-2029)
  • 5.2 Global Infant and Child Multiple Vaccine Consumption Value by Type (2018-2029)
  • 5.3 Global Infant and Child Multiple Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Infant and Child Multiple Vaccine Sales Quantity by Application (2018-2029)
  • 6.2 Global Infant and Child Multiple Vaccine Consumption Value by Application (2018-2029)
  • 6.3 Global Infant and Child Multiple Vaccine Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Infant and Child Multiple Vaccine Sales Quantity by Type (2018-2029)
  • 7.2 North America Infant and Child Multiple Vaccine Sales Quantity by Application (2018-2029)
  • 7.3 North America Infant and Child Multiple Vaccine Market Size by Country
    • 7.3.1 North America Infant and Child Multiple Vaccine Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Infant and Child Multiple Vaccine Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Infant and Child Multiple Vaccine Sales Quantity by Type (2018-2029)
  • 8.2 Europe Infant and Child Multiple Vaccine Sales Quantity by Application (2018-2029)
  • 8.3 Europe Infant and Child Multiple Vaccine Market Size by Country
    • 8.3.1 Europe Infant and Child Multiple Vaccine Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Infant and Child Multiple Vaccine Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Infant and Child Multiple Vaccine Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Infant and Child Multiple Vaccine Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Infant and Child Multiple Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Infant and Child Multiple Vaccine Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Infant and Child Multiple Vaccine Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Infant and Child Multiple Vaccine Sales Quantity by Type (2018-2029)
  • 10.2 South America Infant and Child Multiple Vaccine Sales Quantity by Application (2018-2029)
  • 10.3 South America Infant and Child Multiple Vaccine Market Size by Country
    • 10.3.1 South America Infant and Child Multiple Vaccine Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Infant and Child Multiple Vaccine Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Infant and Child Multiple Vaccine Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Infant and Child Multiple Vaccine Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Infant and Child Multiple Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Infant and Child Multiple Vaccine Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Infant and Child Multiple Vaccine Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Infant and Child Multiple Vaccine Market Drivers
  • 12.2 Infant and Child Multiple Vaccine Market Restraints
  • 12.3 Infant and Child Multiple Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Infant and Child Multiple Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Infant and Child Multiple Vaccine
  • 13.3 Infant and Child Multiple Vaccine Production Process
  • 13.4 Infant and Child Multiple Vaccine Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Infant and Child Multiple Vaccine Typical Distributors
  • 14.3 Infant and Child Multiple Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Infant and Child Multiple Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    The process of upgrading global multi-vaccine products is a process of solidifying the competitive landscape.
    The Global Info Research report includes an overview of the development of the Infant and Child Multiple Vaccine industry chain, the market status of 12 Months Below (Pentavalent Vaccine, Quadruple Vaccine), 12 Months Above (Pentavalent Vaccine, Quadruple Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infant and Child Multiple Vaccine.
    Regionally, the report analyzes the Infant and Child Multiple Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infant and Child Multiple Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Infant and Child Multiple Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infant and Child Multiple Vaccine industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Doses), revenue generated, and market share of different by Type (e.g., Pentavalent Vaccine, Quadruple Vaccine).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infant and Child Multiple Vaccine market.
    Regional Analysis: The report involves examining the Infant and Child Multiple Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infant and Child Multiple Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Infant and Child Multiple Vaccine:
    Company Analysis: Report covers individual Infant and Child Multiple Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infant and Child Multiple Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (12 Months Below, 12 Months Above).
    Technology Analysis: Report covers specific technologies relevant to Infant and Child Multiple Vaccine. It assesses the current state, advancements, and potential future developments in Infant and Child Multiple Vaccine areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infant and Child Multiple Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Infant and Child Multiple Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Pentavalent Vaccine
    Quadruple Vaccine
    Triple Vaccine
    Others
    Market segment by Application
    12 Months Below
    12 Months Above
    Major players covered
    Sanofi
    GSK
    Mitsubishi Tanabe Pharma
    KM Biologics
    Wuhan Institute of Biological Products
    Walvax Biotechnology
    Chengdu Institute of Biological Products
    Minhai Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Infant and Child Multiple Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Infant and Child Multiple Vaccine, with price, sales, revenue and global market share of Infant and Child Multiple Vaccine from 2018 to 2023.
    Chapter 3, the Infant and Child Multiple Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Infant and Child Multiple Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Infant and Child Multiple Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Infant and Child Multiple Vaccine.
    Chapter 14 and 15, to describe Infant and Child Multiple Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now